Header cover image
  • Investing Ideas
  • Australian Pharmaceuticals & Biotech Undervalued Dividend Payers

Australian Pharmaceuticals & Biotech Undervalued Dividend Payers

Results

1

0 new

Companies available at a discount paying at least a 2% dividend yield.

1 companies

CSL

Market Cap: AU$68.4b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

CSL

AU$144.56

7D

-0.5%

1Y

-42.6%